Pricing

Log inSign up

Palvella Therapeutics

0 followers

‌

Palvella Therapeutics was founded with the single-minded goal of serving individuals suffering from serious rare genetic diseases with no approved treatments. By developing pathogenetically targeted therapies that address the root causes of these diseases.

Industries

Biotechnology, Education

Headquarters

Wayne, United States

Employees

11-50

Links

Org chart

Wes Kaupinen
President & CEO
Collapse
Braham Shroot
Chief Scientific Officer
Jeff Martini
Chief Scientific Officer
Kathy Goin
Chief Operating Officer
Emily Cook
SVP, Clinical Operations
Kathleen McGowan
VP, Finance & Operations
Jason Connor
VP, Clinical & Biostatistics
Matthew Korenberg
Chief Financial Officer
Christine Kampf
Vice President, Regulatory Affairs
Ashley Kline
Chief Commercial Officer (cco)

Board & advisors

GJ
George Jenkins
Chairman
Todd Davis
Director
Scott Morenstein
Director
Michael Murray
Observer
JT
James Treat
Advisor
JT
Joyce Teng
Advisor
EO
Edel O’Toole
Advisor
WM
Will Motley
Advisor
SL
Sandy Leachman
Advisor
AH
Alain Hovnanian
Advisor
DB
David Bickers
Advisor
AP
Amy S Paller
Advisor
AA
Aditya Asokan
Director
TW
Tadd S. Wessel
Director

Teams

EO
JT
JT
SL
+5

Advisory Team

9 people · 0 jobs

+3

Leadership Team

7 people · 0 jobs

Clinical and Regulatory Operations

4 people · 0 jobs

LR

Management and Operations

3 people · 0 jobs

Offices

Similar companies

Cellares

4 followers

Tango Therapeutics

3 followers

Dyno Therapeutics

4 followers

Odyssey Therapeutics

2 followers

Gilead Sciences

157 followers

Regeneron

124 followers

Illumina

78 followers

Agilent Technologies

78 followers

Verily Life Sciences

45 followers

Alexion Pharmaceuticals

44 followers

GRAIL

27 followers

Explore companies